If increasing retatrutide from 2 mg to 4 mg, hold cagrilintide at its current dose
Summary: GLP-1 receptor agonists do not directly cause sweating, but some patients report changes in perspiration patterns due to indirect factors such as gastrointestinal side effects, hypoglycaemia when combined with other diabetes medications, or autonomic responses to nausea
This can lead to people having trouble meeting their protein or fiber needs
Chen Z, Deng X, Shi C, Jing H, Tian Y, Zhong J et al
Pioglitazone use and risk of bladder cancer: population based cohort study
Semaglutide works by activating GLP-1 receptors, which stimulates insulin secretion in response to meals, reduces glucagon release, and slows gastric emptying